Related Experiment Video
Updated: May 2, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Long-term outcomes and risk analyses of coronary bypass for left main disease
Yasunori Cho1, Shinichiro Shimura2, Akira Aki1
1Department of Cardiovascular Surgery, Tokai University School of Medicine, Kanagawa, Japan.
Insights
Conventional coronary artery bypass grafting for left main disease shows excellent long-term outcomes. The SYNTAX score predicts major adverse cardiac events, offering a benchmark for percutaneous coronary intervention comparisons.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Retrospective analysis of long-term outcomes for conventional coronary artery bypass grafting (CABG) in patients with left main disease.
- Evaluation of risk predictors for adverse events following CABG.
Purpose of the Study:
- To assess the long-term efficacy and safety of routine CABG for left main coronary artery disease.
- To identify predictors of major adverse cardiac and cerebrovascular events (MACCE) after CABG.
Main Methods:
- Analysis of 193 consecutive patients undergoing CABG for left main disease (2000-2009).
- Long-term follow-up assessing MACCE (all-cause death, stroke, myocardial infarction, repeat revascularization) at 9 years.
- Statistical analysis to determine risk predictors for MACCE.
Main Results:
- Overall 9-year rates: 20.2% combined outcomes, 8.9% repeat revascularization, 27.7% MACCE.
- The SYNTAX score was the sole significant predictor for combined outcomes, repeat revascularization, and MACCE at 9 years.
- Hazard ratios for SYNTAX score: 1.04 (combined outcomes), 1.11 (repeat revascularization), 1.07 (MACCE).
Conclusions:
- Routine CABG for left main disease demonstrates excellent long-term MACCE outcomes.
- The SYNTAX score is a significant predictor of long-term results after CABG for left main disease.
- Findings provide a benchmark for comparing long-term outcomes with percutaneous coronary intervention.
Background:
We retrospectively analyzed the long-term outcomes and risk predictors of conventional coronary artery bypass grafting routinely employed for patients with left main disease.
Methods:
From January 2000 through December 2009, conventional coronary artery bypass grafting was routinely employed in 193 consecutive patients with left main disease. Long-term analyses were performed, looking at the primary endpoint of major adverse cardiac and cerebrovascular events which included all-cause death, stroke, myocardial infarction, and repeat revascularization. We also analyzed the effects of variables on major adverse cardiac and cerebrovascular events at 9 years after the operation.
Results:
The overall 9-year rates of combined outcomes (death, stroke, myocardial infarction), repeat revascularization, and major adverse cardiac and cerebrovascular events were 20.2%, 8.9%, 27.7%, respectively. The SYNTAX score was demonstrated to be the only significant predictor of combined outcomes at 9 years (hazard ratio 1.04, p = 0.033), repeat revascularization at 9 years (hazard ratio 1.11, p = 0.0030), and major adverse cardiac and cerebrovascular events at 9 years (hazard ratio 1.07, p = 0.0003).
Conclusions:
With our routine strategy of conventional coronary artery bypass for left main disease, patients revealed excellent long-term outcomes in terms of major adverse cardiac and cerebrovascular events. These results provide a suitable benchmark against which long-term outcomes of percutaneous coronary intervention for left main disease can be compared. The SYNTAX score, which was introduced to determine treatment for complex coronary disease, is indicative of long-term outcomes after coronary artery bypass for left main disease.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Cardiac Catheterization III: Left Heart Catheterization
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Coronary Artery Disease II: Pathophysiology

